​DACRIN logo

Research in development

At DACRIN, our mission is to facilitate AOD clinical research in NSW. To achieve this, we conduct independent research and collaborate with external organisations. We welcome fresh ideas and initiatives from drug and alcohol health professionals, both members and non-members of DACRIN. Furthermore, we appreciate the input of people with lived experience. Here are some of our upcoming research projects and partnerships:

Study titleLead group
DACRIN 2023-6: SUBLOCADE Long-term Outcomes Study (INDV-6000-406): A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults with Opioid Use Disorder (or Opioid Dependence). DACRIN contributing participants
Indivior
​DACRIN 2023-5: The QuickStart Study: Evaluating same visit rapid point of care hepatitis C testing in community clinics across Australia to increase treatment uptake. DACRIN contributing participants​Burnett Institute
​DACRIN 2023-2: Drug Intoxication Detecion Film Study​DACRIN (NSLHD)
​​DACRIN 2023-1:The eCliPSE (Electronic Clinical Pathways to Service Excellence) project. DACRIN contributing participants​University of Newcastle

DACRIN 2022-1: A placebo-controlled randomised trial of cannabidiol (CBD) in the treatment of cannabis use disorder (ACTRN12623000526673)

DACRIN (SESLHD)

 

Learn more about DACRIN research underway


Current as at: Tuesday 19 December 2023
Contact page owner: Centre for Alcohol and Other Drugs